Stay updated on ATH-1017 Study in Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the ATH-1017 Study in Alzheimer's Clinical Trial page.

Latest updates to the ATH-1017 Study in Alzheimer's Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe record now presents details for the completed Phase 2 ATH-1017 study in mild to moderate Alzheimer’s disease, including eligibility criteria, treatment arms, outcomes, study locations, and study documents.SummaryDifference55%

- Check20 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide banner announces NIH website transition updates and notes that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.SummaryDifference1%

- Check34 days agoChange DetectedThe footer’s site revision marker changed from v3.7.1 to v3.7.2, while the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe site revision marker in the footer changes from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check62 days agoChange DetectedThe ACT-AD study page is now showing a 403 Forbidden error, blocking access to the study details and related documents. This reflects an access issue rather than a substantive update to the study content.SummaryDifference18%

Stay in the know with updates to ATH-1017 Study in Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ATH-1017 Study in Alzheimer's Clinical Trial page.